EYE — Nova Eye Medical Cashflow Statement
0.000.00%
Last trade - 00:00- AU$22.68m
- AU$23.80m
- AU$23.45m
- 54
- 61
- 22
- 44
Annual cashflow statement for Nova Eye Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.858 | 0.027 | 0.041 | 0.489 | 0.511 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.4 | -13.1 | -4.72 | -6.82 | -7.86 |
| Capital Expenditures | -0.943 | -0.809 | -3.72 | -0.567 | -0.449 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 89.3 | -2.17 | -0.819 | -0.13 | 0.124 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 88.3 | -2.98 | -4.54 | -0.697 | -0.325 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -13.3 | -61.6 | -0.402 | 6.82 | 6.91 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 80.5 | -77.8 | -9.8 | -0.581 | -1.27 |